4D MOLECULAR THERAPEUTICS INC.
🏢 View company profile →15Patents
15Active
15Granted
48Portfolio score
Filing activity: May 12, 2017 → Dec 21, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11118192B2 | Adeno-associated virus variant capsids and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US11167041B2 | Adeno-associated virus variant capsids and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US11766489B2 | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | Chemistry; Metallurgy | 4 | Active |
| US11499166B2 | Adeno-associated variants, formulations and methods for pulmonary delivery | Chemistry; Metallurgy | 1 | Active |
| US11198858B2 | Codon optimized GLA genes and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11419949B2 | Adeno-associated virus variant capsids and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11179477B2 | Method of using adeno-associated virus with variant capsid | Chemistry; Metallurgy | 0 | Active |
| US11807868B2 | Adeno-associated variants, formulations and methods for pulmonary delivery | Chemistry; Metallurgy | 0 | Active |
| US11364308B2 | Adeno-associated virus variant capsids and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11766487B2 | Treatments for retinal disease | Chemistry; Metallurgy | 0 | Active |
| US11357870B2 | Codon optimized REP1 genes and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11576983B2 | Treatments for retinal disease | Chemistry; Metallurgy | 0 | Active |
| US11345930B2 | Codon optimized RPGRORF15 genes and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11840704B2 | Adeno-associated virus variant capsids and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11524081B2 | Codon optimized REP1 genes and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.